Autonomix Medical (NASDAQ:AMIX) Stock Lifted to Hold by Wall Street Zen

Wall Street Zen upgraded shares of Autonomix Medical (NASDAQ:AMIX) from a sell rating to a hold rating in a research report report published on Saturday morning,Wall Street Zen reports.

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Autonomix Medical in a research report on Monday, October 26th. One research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $42.00.

Autonomix Medical Price Performance

AMIX traded up $0.01 during trading hours on Friday, reaching $1.37. 201,404 shares of the stock traded hands, compared to its average volume of 3,764,439. The firm’s fifty day simple moving average is $3.06 and its two-hundred day simple moving average is $6.40. The company has a market cap of $1.33 million, a price-to-earnings ratio of -0.03 and a beta of -0.70. Autonomix Medical has a fifty-two week low of $1.30 and a fifty-two week high of $32.55.

Autonomix Medical (NASDAQ:AMIX) last released its quarterly earnings results on Tuesday, November 10th. The company reported ($2.51) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.62) by $0.11. On average, research analysts predict that Autonomix Medical will post -20.17 earnings per share for the current year.

About Autonomix Medical

Autonomix Medical, Inc. is a medical device company developing catheter-based technologies for the detection and treatment of conditions involving the peripheral nervous system. The company’s platform is designed to identify neural signals in real time, with the goal of helping physicians locate and selectively treat targeted nerves during minimally invasive procedures. Autonomix’s lead development program is focused on pain associated with pancreatic cancer. Its technology is intended to support targeted nerve ablation, potentially offering an alternative approach for managing pain while reducing the need for more extensive procedures.